(Q38300283)

English

Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression

scientific article published on June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 September 2017

Suppression of DPYD expression in RKO cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression (English)

1 reference

Europe PubMed Central

1 September 2017

DNA methylation

0 references

author name string

Xue Zhang

1

1 reference

Europe PubMed Central

1 September 2017

Richie Soong

2

1 reference

Europe PubMed Central

1 September 2017

Kangsheng Wang

3

1 reference

Europe PubMed Central

1 September 2017

Lin Li

4

1 reference

Europe PubMed Central

1 September 2017

James R Davie

5

1 reference

Europe PubMed Central

1 September 2017

Vincenzo Guarcello

6

1 reference

Europe PubMed Central

1 September 2017

Robert B Diasio

7

1 reference

Europe PubMed Central

1 September 2017

publication date

1 June 2007

1 reference

Europe PubMed Central

1 September 2017

Biochemistry and Cell Biology

1 reference

Europe PubMed Central

1 September 2017

85

1 reference

Europe PubMed Central

1 September 2017

3

1 reference

Europe PubMed Central

1 September 2017

337-346

1 reference

Europe PubMed Central

1 September 2017

Increased dihydropyrimidine dehydrogenase activity in breast cancer

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation.

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Crystal structure of dihydropyrimidine dehydrogenase, a major determinant of the pharmacokinetics of the anti-cancer drug 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Methylation of the DPYD promoter: an alternative mechanism for dihydropyrimidine dehydrogenase deficiency in cancer patients

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

DNA methyltransferase inhibitors-state of the art.

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Differential intranuclear organization of transcription factors Sp1 and Sp3.

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Epigenetics: The Role of Methylation in the Mechanism of Action of Tumor Suppressor Genes

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

DNA methylation, a biomarker for colorectal cancer: implications for screening and pathological utility.

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Methods for analyzing the role of DNA methylation and chromatin structure in regulating T lymphocyte gene expression

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

The uracil breath test in the assessment of dihydropyrimidine dehydrogenase activity: pharmacokinetic relationship between expired 13CO2 and plasma [2-13C]dihydrouracil

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics.

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Cancer epigenetics

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

The dioxin receptor is silenced by promoter hypermethylation in human acute lymphoblastic leukemia through inhibition of Sp1 binding.

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

DNA methylation as a cancer-specific biomarker: from molecules to populations

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Molecular cloning and characterization of the human dihydropyrimidine dehydrogenase promoter

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells.

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter

1 reference

https://api.crossref.org/works/10.1139%2FO07-009

21 January 2018

Identifiers

10.1139/O07-009

1 reference

Europe PubMed Central

1 September 2017

release_a5tohn5nlvcjrokqznhfbfrgxa

1 reference

https://api.fatcat.wiki/v0/release/a5tohn5nlvcjrokqznhfbfrgxa

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

1 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38300283&oldid=1840303230"